Dr. Emmanuel Alexandrakis, Consultant and Global Strategist for the Health Economy at the WifOR Institute – Adjunct Professor MBA International, Athens University of Economics and Business
With over 30 years of professional experience as an economist, and an extensive University level teaching and research background, Dr. Alexandrakis has a combined managerial, research, public policy, and strategy analysis background, with a special focus in the health sector. He has served executive positions in the pharmaceutical sector and as a high-level government official in Greece and the EU.
Today, he is a consultant and Global Strategist for the Health Economy at the WifOR Institute, a German independent Economic Research Organization, with global activity. He is also Adjunct Professor at the MBA International Program of the Athens University of Economics and Business for Health Sector Strategy and Member of the Business Advisory Council (BAC) of the Program. In parallel, he is a Senior Research Fellow – Coordinator at the Health Sector Research Center (HealthSec) of the Management Science Laboratory of the same University. He has recently served as an Executive Member of the BoD of the Hellenic Archaeological Proceeds Fund and is also a Research Associate of the University of Piraeus Laboratory of Health Economics and Management. Dr. Alexandrakis is a member of Advisory Committees and Boards (ie. G20 Health & Development Partnership, Greek Insurance Association Committee for Prevention, and Insurance Fraud) and has also served internationally as an expert on the Expert Review Board of the WHO – European Office for Investment for Health and Development for Health Economy, to the Government of Kazakhstan etc.
Before joining the Pharmaceutical Company MSD in 2012 (known as Merck & Co., Inc. in the USA, and Canada) to lead the Policy, Communications and Corporate Social Responsibility (CSR) activities in Greece and Cyprus, he had served as a Senior Advisor at the Hellenic Parliament, with a key responsibility on the Economic Adjustment Program of Greece and issues related to fiscal policies and legislation. Before that, for several years, he served at high-level government positions and Committees in Greece and the EU (Special State Secretary of the Hellenic Ministry of Tourism, Managing Director for Administration of the National Theatre of Greece, CEO of the Greek State Healthcare Organization for Seamen, Coordinator of PPP and Investment Committees, and has actively participated in several Committees that relate to Innovation and Entrepreneurship, the Pharmaceutical Industry, the Health sector, Tourism, the Insurance sector, and served as a Scientific Advisor at the Economic and Social Council of Greece.